This study was directed to the investigation of two different aspects of growth hormone: What are the metabolic consequences following the discontinuation of treatment and are these metabolic effects correlated with the growth-promoting effects seen in the first year of treatment? The study was performed on 12 growth hormone-deficient (GHD) patients who reached their final height. Each patient was matched with a non-GHD person of the same sex and about the same age. Immediately after the discontinuation of treatment, and 6 weeks and 6 months later, the following anthropometric variables were assessed: height, weight, skinfold thicknesses (biceps, triceps, subscapular and suprailiacal), body volume (underwater weighing) and total body water (deuterium dilution). To describe energy metabolism, basal metabolic rate assessed by ventilated hood, and sleep metabolic rate assessed by respiration chamber, were studied. Body composition was calculated from weight, volume and total body water. Clear metabolic effects were found after the discontinuation of treatment in GHD children: there was a decrease in fat free mass and sleep metabolic rate. Also, a strong correlation between the above-mentioned effects and the growth-promoting effects of human growth hormone at the beginning of the treatment was observed. The fact that this correlation exists poses the interesting question of whether the results from a test treatment lasting some weeks could be used to predict the long-term effects of hGH.

Keywords:
Growth hormone, Body composition, Metabolism, Metabolic rate
1.
Ikkos D, Luft R, Gemzell CA: The effect of human growth hormone in man. Lancet 1958; i:720–721.
2.
Dahms WT, Owens RP, Kalhan SC, Kerr DS, Danish RK: Urea synthesis, nitrogen balance, and glucose turnover in growth-hormone-deficient children before and after growth hormone administration. Metabolism 1989;38:197–203.
3.
Gregory JW, Greene SA, Jung RT, Scrimgeour CM, Rennie MJ: Changes in body composition and energy expenditure after six weeks’ growth hormone treatment. Arch Dis Child 1991;66:598–602.
4.
Dempsher DP, Bier DM, Tollefsen SE, et al: Whole body nitrogen kinetics and their relationship to growth in short children treated with recombinant human growth hormone. Pediatr Res 1990;28:394–400.
5.
Weiner JS, Lourie JA: Human Biology: A Guide to Field Methods. Oxford, International Biological Programme Handbook, vol 9. Blackwell Scientific, 1969.
6.
Siri WE: Body composition from fluid spaces and density: Analysis of methods; in Brozek J, Henschel A (eds): Techniques for Measuring Body Composition. Washington, National Academy of Sciences, 1961, pp 223–244.
7.
Gerver WJM, Bruin RD: Paediatric Morphometrics: A Reference Manual, ed 1. Utrecht, Bunge, 1996.
8.
Durnin JVGA, Rahaman MM: The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 1967;21:681–689.
9.
Prader A, Hernesniemi I, Zachmann M: Skinfold thickness in infancy and adolescence: A longitudinal correlation study in normal children. Pediatr Adolesc Endocrinol 1976;1:84–88.
10.
Deurenberg P, Pieters JJL, Hautvast JGAJ: The assessment of the body fat percentage by skinfold thickness measurements in childhood and young adolescence. Br J Nutr 1990;63:293–303.
11.
Weststrate JA, Deurenberg P: Body composition in children: Proposal for a method for calculating body fat percentage from total body density or skinfold-thickness measurements. Am J Clin Nutr 1989;50:1104–1115.
12.
Deurenberg P, Weststrate JA, Seidell JC: Body mass index as a measure of body fatness: Age- and sex-specific prediction formulas. Br J Nutr 1991;65:105–114.
13.
Hindmarsh PC, Swift PGF: An assessment of growth hormone provocation tests. Arch Dis Child 1995;72:362–368.
14.
Gregory JW, Greene SA, Jung RT, Scrimgeour CM, Rennie MJ: Metabolic effects of growth hormone treatment: An early predictor of growth response? Arch Dis Child 1993;68:205–209.
15.
Vaisman N, Zadik Z, Shamai Y: Changes in body composition of patients with subnormal spontaneous secretion of growth hormone, during the first year of treatment with growth hormone. Metabolism 1992;41:483–486.
16.
Vaisman N, Zadik Z, Akivias A, et al: Changes in body composition, resting energy expenditure, and thermic effect of food in short children on growth hormone therapy. Metabolism 1994;43:1543–1548.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.